TP53 and colorectal carcinoma: In addition, mutated p53 genes could positively feedback, and the expression of LINC00460 was upregulated, forming the LINC00460-miR-149-5p/miR-150-5p-MUT p53 axis, leading to drug resistance in CRC [71].